ClearPoint Neuro, Inc.
CLPT
$14.90
$0.332.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -10.29% | 16.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.29% | 16.50% | |||
| Cost of Revenue | -4.62% | 9.14% | |||
| Gross Profit | -13.49% | 21.11% | |||
| SG&A Expenses | 5.21% | 39.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.51% | 31.63% | |||
| Operating Income | -20.83% | -61.64% | |||
| Income Before Tax | -19.18% | -22.64% | |||
| Income Tax Expenses | -575.00% | 100.00% | |||
| Earnings from Continuing Operations | -18.69% | -22.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.69% | -22.68% | |||
| EBIT | -20.83% | -61.64% | |||
| EBITDA | -20.82% | -66.13% | |||
| EPS Basic | -16.24% | -19.79% | |||
| Normalized Basic EPS | -16.74% | -55.79% | |||
| EPS Diluted | -16.24% | -19.79% | |||
| Normalized Diluted EPS | -16.74% | -55.79% | |||
| Average Basic Shares Outstanding | 2.10% | 2.42% | |||
| Average Diluted Shares Outstanding | 2.10% | 2.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||